Trial NCT04267913

View at ClinicalTrials.gov 
Org. Study IDs: S1900D
Secondary IDs: NCI-2020-00171 S1900D U10CA180888

Last trial update was posted on 2020-11-20

MeSH Interventions

Antibodies Antibodies, Monoclonal Antineoplastic Agents, Immunological BB 1101 Dexamethasone Dexamethasone acetate Docetaxel Immunoglobulins Lexatumumab Ramucirumab

MeSH Conditions

Carcinoma Lung Neoplasms

Other Conditions

Lung Squamous Cell Carcinoma Recurrent Lung Carcinoma Stage IV Lung Cancer AJCC v8 Stage IVA Lung Cancer AJCC v8 Stage IVB Lung Cancer AJCC v8

Stopping Reasons

The pharmaceutical company sold the compound and pulled out.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID